Loading clinical trials...
Loading clinical trials...
The objective of the RELIEF Study is to compare the safety, effectiveness and patient experience outcomes in real-world subjects treated with different modalities for symptomatic BPH.
Age
45 - No limit years
Sex
MALE
Healthy Volunteers
No
Neotract Inc
Pleasanton, California, United States
Start Date
January 26, 2025
Primary Completion Date
January 26, 2026
Completion Date
September 24, 2026
Last Updated
March 11, 2026
UroLift System
DEVICE
Watchful Waiting or BPH Medications
OTHER
Other Surgical Intervention
DEVICE
Lead Sponsor
NeoTract, Inc.
NCT07016620
NCT06312722
NCT06817733
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions